| Patrick J Gould, CRNA | |
|
1001 Gause Blvd, Slidell, LA 70458-2939 | |
| (985) 280-2200 | |
| Not Available |
| Full Name | Patrick J Gould |
|---|---|
| Gender | Male |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 30 Years |
| Location | 1001 Gause Blvd, Slidell, Louisiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1396713384 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | ARNP3146742 (Florida) | Secondary |
| 367500000X | Nurse Anesthetist, Certified Registered | 227292 (Louisiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Slidell Memorial Hospital | Slidell, LA | Hospital |
| Tulane Medical Center | New orleans, LA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Childrens Hospital Anesthesia Corporation | 0446152862 | 221 |
| Ochsner Clinic Llc | 8224933619 | 2403 |
News Archive
The Food and Drug Administration (FDA) in the United States has given it's approval for the first patch for Parkinson's disease.
The cause of a rare type of ovarian cancer that most often strikes girls and young women has been uncovered by an international research team led by the Translational Genomics Research Institute, according to a study published online today by the renowned scientific journal, Nature Genetics.
Researchers have found that a biological clock can influence a heart attack. The risk of "sudden cardiac death" peaks in the morning and rises again in the evening as shown in lab animals.
AstraZeneca and Bristol-Myers Squibb Company announced the U.S. Food and Drug Administration approved Farxiga™ [far-SEE-ga] (dapagliflozin), a once-daily oral treatment indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
› Verified 4 days ago
| Entity Name | Ochsner Clinic Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538151428 PECOS PAC ID: 8224933619 Enrollment ID: O20031126000513 |
News Archive
The Food and Drug Administration (FDA) in the United States has given it's approval for the first patch for Parkinson's disease.
The cause of a rare type of ovarian cancer that most often strikes girls and young women has been uncovered by an international research team led by the Translational Genomics Research Institute, according to a study published online today by the renowned scientific journal, Nature Genetics.
Researchers have found that a biological clock can influence a heart attack. The risk of "sudden cardiac death" peaks in the morning and rises again in the evening as shown in lab animals.
AstraZeneca and Bristol-Myers Squibb Company announced the U.S. Food and Drug Administration approved Farxiga™ [far-SEE-ga] (dapagliflozin), a once-daily oral treatment indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
› Verified 4 days ago
| Entity Name | Childrens Hospital Anesthesia Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649362740 PECOS PAC ID: 0446152862 Enrollment ID: O20040124000258 |
News Archive
The Food and Drug Administration (FDA) in the United States has given it's approval for the first patch for Parkinson's disease.
The cause of a rare type of ovarian cancer that most often strikes girls and young women has been uncovered by an international research team led by the Translational Genomics Research Institute, according to a study published online today by the renowned scientific journal, Nature Genetics.
Researchers have found that a biological clock can influence a heart attack. The risk of "sudden cardiac death" peaks in the morning and rises again in the evening as shown in lab animals.
AstraZeneca and Bristol-Myers Squibb Company announced the U.S. Food and Drug Administration approved Farxiga™ [far-SEE-ga] (dapagliflozin), a once-daily oral treatment indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
› Verified 4 days ago
| Entity Name | Aec Physicians, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346574217 PECOS PAC ID: 6305983214 Enrollment ID: O20091027000035 |
News Archive
The Food and Drug Administration (FDA) in the United States has given it's approval for the first patch for Parkinson's disease.
The cause of a rare type of ovarian cancer that most often strikes girls and young women has been uncovered by an international research team led by the Translational Genomics Research Institute, according to a study published online today by the renowned scientific journal, Nature Genetics.
Researchers have found that a biological clock can influence a heart attack. The risk of "sudden cardiac death" peaks in the morning and rises again in the evening as shown in lab animals.
AstraZeneca and Bristol-Myers Squibb Company announced the U.S. Food and Drug Administration approved Farxiga™ [far-SEE-ga] (dapagliflozin), a once-daily oral treatment indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Patrick J Gould, CRNA 1514 Jefferson Hwy, New Orleans, LA 70121-2429 Ph: (504) 842-4000 | Patrick J Gould, CRNA 1001 Gause Blvd, Slidell, LA 70458-2939 Ph: (985) 280-2200 |
News Archive
The Food and Drug Administration (FDA) in the United States has given it's approval for the first patch for Parkinson's disease.
The cause of a rare type of ovarian cancer that most often strikes girls and young women has been uncovered by an international research team led by the Translational Genomics Research Institute, according to a study published online today by the renowned scientific journal, Nature Genetics.
Researchers have found that a biological clock can influence a heart attack. The risk of "sudden cardiac death" peaks in the morning and rises again in the evening as shown in lab animals.
AstraZeneca and Bristol-Myers Squibb Company announced the U.S. Food and Drug Administration approved Farxiga™ [far-SEE-ga] (dapagliflozin), a once-daily oral treatment indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
› Verified 4 days ago
Patrick M Fried, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 1700 Lindberg Dr, Slidell, LA 70458 Phone: 985-641-8008 Fax: 985-649-4063 | |
Susan J. Aycock, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1001 Gause Blvd, Slidell, LA 70458 Phone: 985-649-8767 | |
Geoffrey S Fendley, MSNA, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1001 Gause Blvd, Slidell, LA 70458 Phone: 985-280-2200 | |
Christopher Trainor, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 1001 Gause Blvd, Slidell, LA 70458 Phone: 985-280-2200 | |
Catherine Parmley, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 1001 Gause Blvd, Slidell, LA 70458 Phone: 985-892-3225 Fax: 985-234-0628 | |
Judith S. Baker, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1001 Gause Blvd, Slidell, LA 70458 Phone: 985-649-8767 | |
Catherine M Marrione, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1001 Gause Blvd, Slidell, LA 70458 Phone: 985-649-8767 |